Performance of the Project. Each Party shall carry out the research and tasks which it is specified to perform in the project plan set out in Schedule 2, and provide the human resources, materials, facilities and equipment that are designated to be provided by it in the project plan, in each case in a timely manner, in accordance with good accepted research practice and all applicable laws, and with due regard for the health and safety of those involved in the Project.
Performance of the Project. The Funding Recipient must, and must ensure that its Personnel must:
Performance of the Project. 4.1 During the Term of this Agreement, Emory agrees:
Performance of the Project. 2.1 At the commencement of the PROJECT, both PARTIES hereby expressly acknowledge that both PARTIES are uncertain whether the PARTIES will complete the PROJECT and achieve the results of the PROJECT.
Performance of the Project. The concrete content of the contribution of each Party in the Project is described in detail in the Proposal known by all Parties and attached to this document (Exhibit 2). The Parties will collaborate in good faith in order to implement the Project as set out in the Proposal. Each Party will use its best endeavours to carry out the Project in a timely and efficient manner. Each Party shall perform the tasks allotted to it in the Proposal and provide the human resources, materials, facilities and equipment that are designated as its responsibility in the Proposal. The Parties will ensure to exchange, and where necessary request, all necessary information without impairing any obligation of confidentiality. No warranty regarding outcome of scientific research. Although each of the Parties will use its best endeavours to carry out the Project in accordance with the Proposal, no Party undertakes that any research will lead to any particular result, nor does it guarantee a successful outcome to the Project.
Performance of the Project. 3.1. Each Party agrees to:
Performance of the Project. Patheon will perform the Project in compliance with the terms and conditions of this Agreement, AcelRx’s instructions, and all applicable laws and regulations. Patheon will perform the Project in accordance with the timeline that will be established by the combined Patheon-AcelRx Project team. This timeline may be modified by mutual agreement of the parties. With respect to the Dedicated Equipment that will be transferred from Patheon Canada’s facilities to the Facility, AcelRx will be responsible for the packaging and transport of the Dedicated Equipment to the Facility. Patheon Canada will allow and support access to the Dedicated Equipment by the AcelRx packaging/transport contractor(s). AcelRx will bear the risk of loss of or damage to the Dedicated Equipment during transit to the Facility, and will obtain insurance covering such risk of loss or damage while in transit. AcelRx will be responsible for obtaining appropriate import and related documentation for the transport of the Dedicated Equipment. Once delivered to the Facility, Patheon will be responsible for the installation of the Dedicated Equipment and for any risk of damage thereof.
Performance of the Project. 3.1 The Parties shall provide each other with all of the information needed for the performance of the Project following prior coordination. Any documents, objects or other resources which one of the Parties needs in order to perform the work shall be provided by the other Party as far as possible. They shall be used exclusively for the purposes of performing the Project. STELLAR will in particular make available to BIG within a time period of thirty (30) days from the Effective Date or in case of the last bullet point immediately after production of the data and results: · a report including all information about the Improved KLHsu Production Method and/or all information useful or needed to obtain the Improved KLHsu Production Method including confidential manufacturing and analytical protocols, process development plans as well as all experimental data that support the expectation of the 60% yield (but not less than a 50% yield) of the purified KLHsu, · all limpets ((Megathura crenulata) required for production of ASP KLH for the Project, · all ASP KLH required for BIG to perform the Project, · the Drug Master File (DMF) on STELLAR´s current KLHsu, · all analytical and preclinical data and study results produced by STELLAR in the development, evaluation and validation of the Improved KLHsu Production Method and any comparability testing of STELLAR’s KLHsu. BIG will in particular make available to STELLAR: • all KLHsu material produced from STELLAR ASP KLH initially provided pursuant to paragraph 3.1 but not specifically required to perform the Project, • all preclinical data and study results produced by BIG in the development, evaluation and validation of the Improved KLHsu Production Method and comparability testing of STELLAR’s KLHsu which BIG is allowed to forward to STELLAR and which is necessary for STELLAR .
Performance of the Project. City shall perform or otherwise enter into a contract for the performance of the Project in accordance with plans, designs and schedules as submitted to County by City on or before the full execution of this Agreement. City shall be solely responsible for all costs of the Project.
Performance of the Project. The Researcher shall properly manage and monitor the Project and inform AHDB in Writing without undue delay if any aspect of the Agreement is not being or is unable to be performed. The Researcher shall provide all the facilities necessary to complete the Project. Any materials or processes used in connection with the carrying out of the Project shall be in accordance with standards set out in the Agreement. The Researcher shall carry out the Project in accordance with the Specification; ensure that its employees, agents and sub-contractors act with reasonable skill, care and diligence; and deliver the Results to AHDB. The Researcher shall take reasonable steps to follow best professional or good industry practice and ensure compliance with all applicable laws, codes of practice including the Joint Code of Practice for Research1, guidelines and any Standards set out in the Specification, including acting in accordance with relevant research governance principles, by itself and its servants, employees, agents and sub-contractors. The Researcher confirms that: it will comply with best practice and relevant provisions, whether statutory or otherwise, relating to health and safety at work; it will comply with the Data Protection Legislation; and it will not unlawfully discriminate within the meaning and scope of the provisions of the Equality Xxx 0000. The Researcher confirms that in entering into the Agreement it has not: colluded with any competitor in formulating its offer to undertake the Project except insofar as any such competitor is a named participant in a consortium in relation to the Project of which the Researcher is also a participant; canvassed any person associated with AHDB or otherwise sought improperly to improve its competitive position in relation to this Agreement; done or omitted to do anything that would result in a breach of the Bribery Act. The Parties recognise that: this Agreement may provide for the carrying out of experimental research and its undertaking may involve or produce experimental materials, data or processes whose properties and safety may not have been established and any such provided by the Researcher in relation to the Project are supplied ‘as is’ and without any express or implied warranties, representations or undertakings; and unless otherwise agreed, the Researcher does not undertake that the Project will provide specific results or provide data which can be used for a particular purpose. This Agreement shall be ...
